Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

New MAP4K 1inhibitors identified at Merck & Co.

June 2, 2022

Almac Discovery selects peptide-drug conjugate ADP-c389 for preclinical development

June 2, 2022

SRSF9 overexpression correlates with CRC lymph node metastasis and Dukes stage

June 1, 2022

Betta Pharmaceuticals describes histone acetyltransferase KAT3B inhibitors

June 1, 2022

Zydus Lifesciences patents bacterial dihydrofolate reductase inhibitors

June 1, 2022

Arvinas Operations describes PROTACs for androgen receptor degradation

June 1, 2022

New CD73 inhibitors patented by Humanwell Healthcare

May 31, 2022

New menin/MLL interaction inhibitors synthesized at Shanghai Euregen Biopharma

May 31, 2022

SLC13A5 inhibitors identified at the Rosalind Franklin University of Medicine and Science

May 31, 2022

Discovery of novel orally bioavailable SERD with enhanced pharmacological properties

May 31, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...